Page last updated: 2024-11-07

spironolactone and Leukemia, Myeloid, Acute

spironolactone has been researched along with Leukemia, Myeloid, Acute in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fairbanks, VF1
Shanbrom, E1
Steinfeld, JL1
Beutler, E1

Other Studies

1 other study available for spironolactone and Leukemia, Myeloid, Acute

ArticleYear
Prolonged remissions in acute myelocytic leukemia in adults.
    JAMA, 1968, May-13, Volume: 204, Issue:7

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Alkylating Agents; Colchicine; Female;

1968